Stockreport

Gilead's remdesivir cut mortality risk 62% in COVID-19 study [Seeking Alpha]

Morgan Stanley  (MS) 
Last morgan stanley earnings: 4/16 07:15 am Check Earnings Report
US:NYSE Investor Relations: morganstanley.com/about-us-ir
PDF Healthcare|On the MoveGilead's remdesivir cut mortality risk 62% in COVID-19 studyJul. 10, 2020 9:08 AM ETGilead Sciences, Inc. (GILD)Douglas W. HouseGilead Sciences (N [Read more]